Liu, B., Yi, Z., Guan, Y., Ouyang, Q., Li, C., Guan, X., . . . Zeng, Y. (2022). Molecular landscape of TP53 mutations in breast cancer and their utility for predicting the response to HER-targeted therapy in HER2 amplification-positive and HER2 mutation-positive amplification-negative patients. Cancer medicine, 11(14), p. 2767. doi:10.1002/cam4.4652
Chicago ZitierstilLiu, Binliang, et al. "Molecular Landscape of TP53 Mutations in Breast Cancer and Their Utility for Predicting the Response to HER-targeted Therapy in HER2 Amplification-positive and HER2 Mutation-positive Amplification-negative Patients." Cancer Medicine 11, no. 14 (2022): 2767.
MLA ZitierstilLiu, Binliang, et al. "Molecular Landscape of TP53 Mutations in Breast Cancer and Their Utility for Predicting the Response to HER-targeted Therapy in HER2 Amplification-positive and HER2 Mutation-positive Amplification-negative Patients." Cancer Medicine 11.14 (2022): 2767.